Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2026-02-05 @ 12:41 PM
Study NCT ID:
NCT02446795
Status:
UNKNOWN
Last Update Posted:
2017-01-18
First Post:
2015-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Sponsor:
Consorzio Oncotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-12
Completion Date Type:
ESTIMATED
First Submit Date:
2015-05-06
First Submit QC Date:
None
Study First Post Date:
2015-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-16
Last Update Post Date:
2017-01-18
Last Update Post Date Type:
ESTIMATED